申请人:E. R. Squibb & Sons, Inc.
公开号:US04051246A1
公开(公告)日:1977-09-27
Compounds of the following formula ##STR1## wherein R.sup.1 and R.sup.2 are independently selected from hydrogen, halogen, lower alkyl, lower alkoxy, lower alkylthio, nitro, cyano, and trifluoromethyl, and R is selected from a triacetyl substituted pentose, pentose, a tetraacetyl substituted hexose, hexose, a hydroxy substituted cycloalkyl of 5 to 7 carbons, ##STR2## wherein n is 1 or 2 and R.sup.3 is hydrogen, an alkali metal or alkaline earth metal ion; are disclosed. These compounds possess useful anti-inflammatory activity.
以下化合物的结构式为##STR1## 其中R.sup.1和R.sup.2独立地选自氢、卤素、低烷基、低烷氧基、低烷硫基、硝基、氰基和三氟甲基,而R则选自三乙酰基取代的戊糖、戊糖、四乙酰基取代的己糖、己糖、5到7个碳的羟基取代的环烷基,##STR2## 其中n为1或2,R.sup.3为氢、碱金属或碱土金属离子。这些化合物具有有用的抗炎活性。